Kevin Chapman

Kevin Chapman is an Advisor to Celesta. Holding more than 50 US and international patents, his background lies in pharmaceutical discovery and technology development for target validation, biomarker discovery, and medicinal and combinatorial chemistry. Prior to Celesta, Kevin was Chief Science Officer of Berkeley Lights for eight years and for 20 years, he held various senior management roles at Merck & Co.